ReviewBMC cancer2023

Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.

Jing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.